Cite
HARVARD Citation
Quhal, F. et al. (2021). Adverse events of systemic immune-based combination therapies in the first-line treatment of patients with metastatic renal cell carcinoma. Current opinion in urology. 31 (4), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Quhal, F. et al. (2021). Adverse events of systemic immune-based combination therapies in the first-line treatment of patients with metastatic renal cell carcinoma. Current opinion in urology. 31 (4), p. . [Online].